aluates Reports

$ 0.0

Automative

Global Alzheimer's Disease Diagnosis Market Research Report 2026

Published Date: 2026-01-30

Report Code: QYRE-Auto-2N18624

Global Alzheimer s Disease Diagnosis Market Research Report 2024

BUY CHAPTERS

Global Alzheimer's Disease Diagnosis Market Research Report 2026

Code: QYRE-Auto-2N18624

Report

2026-01-30

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Quanterix

Quest Diagnostics

C₂N Diagnostics

Fujirebio

DIADEM

LabCorp

Neurocode

Cognitact

Vazyme International

Kingmed Diagnostics

Hoyotek

EUROIMMUN Medical Diagnostics

Carrier Biomed

Alzheimer's Disease Diagnosis Market

The global Alzheimer's Disease Diagnosis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The Alzheimer's Disease Diagnosis market encompasses the tools, technologies, and services used to detect and diagnose Alzheimer's disease, a progressive neurodegenerative disorder. This market includes diagnostic methods such as imaging techniques (like PET, MRI, and CT scans), biomarker testing (blood, cerebrospinal fluid, and genetic testing), cognitive assessment tools, and novel diagnostic solutions like digital health tools and AI-based diagnostics. The growing prevalence of Alzheimer’s, increasing awareness of early detection, and advancements in diagnostic technologies are driving market growth. Pharmaceutical companies, research institutions, and healthcare providers play key roles in expanding diagnostic options. However, challenges such as the high cost of advanced diagnostic tools and limited access to specialized testing in certain regions can restrain the market’s growth. The Alzheimer's Disease Diagnosis market is critical for facilitating early and accurate diagnosis, which can improve patient management and outcomes.

The North American market for Alzheimer's Disease Diagnosis is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Alzheimer's Disease Diagnosis is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Alzheimer's Disease Diagnosis in Clinical Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Alzheimer's Disease Diagnosis include Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, EUROIMMUN Medical Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Alzheimer's Disease Diagnosis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Alzheimer's Disease Diagnosis. The Alzheimer's Disease Diagnosis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Alzheimer's Disease Diagnosis market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Alzheimer's Disease Diagnosis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Alzheimer's Disease Diagnosis Market Report

Report Metric	Details
Report Name	Alzheimer's Disease Diagnosis Market
Segment by Type	Neuroimaging Examination Cerebrospinal Fluid Examination Peripheral Blood Antibody Examination Others
Segment by Application	Clinical Diagnosis Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, EUROIMMUN Medical Diagnostics, Vazyme International, KingMed Diagnostics, Hoyotek, Carrier Biomed
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Alzheimer's Disease Diagnosis companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Alzheimer's Disease Diagnosis Market report?

Ans: The main players in the Alzheimer's Disease Diagnosis Market are Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, EUROIMMUN Medical Diagnostics, Vazyme International, KingMed Diagnostics, Hoyotek, Carrier Biomed

What are the Application segmentation covered in the Alzheimer's Disease Diagnosis Market report?

Ans: The Applications covered in the Alzheimer's Disease Diagnosis Market report are Clinical Diagnosis, Research

What are the Type segmentation covered in the Alzheimer's Disease Diagnosis Market report?

Ans: The Types covered in the Alzheimer's Disease Diagnosis Market report are Neuroimaging Examination, Cerebrospinal Fluid Examination, Peripheral Blood Antibody Examination, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimer's Disease Diagnosis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Neuroimaging Examination

1.2.3 Cerebrospinal Fluid Examination

1.2.4 Peripheral Blood Antibody Examination

1.2.5 Others

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Diagnosis Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Clinical Diagnosis

1.3.3 Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alzheimer's Disease Diagnosis Market Perspective (2021–2032)

2.2 Global Alzheimer's Disease Diagnosis Growth Trends by Region

2.2.1 Global Alzheimer's Disease Diagnosis Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Alzheimer's Disease Diagnosis Historic Market Size by Region (2021–2026)

2.2.3 Alzheimer's Disease Diagnosis Forecasted Market Size by Region (2027–2032)

2.3 Alzheimer's Disease Diagnosis Market Dynamics

2.3.1 Alzheimer's Disease Diagnosis Industry Trends

2.3.2 Alzheimer's Disease Diagnosis Market Drivers

2.3.3 Alzheimer's Disease Diagnosis Market Challenges

2.3.4 Alzheimer's Disease Diagnosis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Alzheimer's Disease Diagnosis Players by Revenue

3.1.1 Global Top Alzheimer's Disease Diagnosis Players by Revenue (2021–2026)

3.1.2 Global Alzheimer's Disease Diagnosis Revenue Market Share by Players (2021–2026)

3.2 Global Top Alzheimer's Disease Diagnosis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Alzheimer's Disease Diagnosis Revenue

3.4 Global Alzheimer's Disease Diagnosis Market Concentration Ratio

3.4.1 Global Alzheimer's Disease Diagnosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnosis Revenue in 2025

3.5 Global Key Players of Alzheimer's Disease Diagnosis Head Offices and Areas Served

3.6 Global Key Players of Alzheimer's Disease Diagnosis, Products and Applications

3.7 Global Key Players of Alzheimer's Disease Diagnosis, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Alzheimer's Disease Diagnosis Breakdown Data by Type

4.1 Global Alzheimer's Disease Diagnosis Historic Market Size by Type (2021–2026)

4.2 Global Alzheimer's Disease Diagnosis Forecasted Market Size by Type (2027–2032)

5 Alzheimer's Disease Diagnosis Breakdown Data by Application

5.1 Global Alzheimer's Disease Diagnosis Historic Market Size by Application (2021–2026)

5.2 Global Alzheimer's Disease Diagnosis Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Alzheimer's Disease Diagnosis Market Size (2021–2032)

6.2 North America Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Alzheimer's Disease Diagnosis Market Size by Country (2021–2026)

6.4 North America Alzheimer's Disease Diagnosis Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Alzheimer's Disease Diagnosis Market Size (2021–2032)

7.2 Europe Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Alzheimer's Disease Diagnosis Market Size by Country (2021–2026)

7.4 Europe Alzheimer's Disease Diagnosis Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Alzheimer's Disease Diagnosis Market Size (2021–2032)

8.2 Asia-Pacific Alzheimer's Disease Diagnosis Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2021–2026)

8.4 Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Alzheimer's Disease Diagnosis Market Size (2021–2032)

9.2 Latin America Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Alzheimer's Disease Diagnosis Market Size by Country (2021–2026)

9.4 Latin America Alzheimer's Disease Diagnosis Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Alzheimer's Disease Diagnosis Market Size (2021–2032)

10.2 Middle East & Africa Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2021–2026)

10.4 Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Alzheimer's Disease Diagnosis Introduction

11.1.4 Roche Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Quanterix

11.2.1 Quanterix Company Details

11.2.2 Quanterix Business Overview

11.2.3 Quanterix Alzheimer's Disease Diagnosis Introduction

11.2.4 Quanterix Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.2.5 Quanterix Recent Development

11.3 Quest Diagnostics

11.3.1 Quest Diagnostics Company Details

11.3.2 Quest Diagnostics Business Overview

11.3.3 Quest Diagnostics Alzheimer's Disease Diagnosis Introduction

11.3.4 Quest Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.3.5 Quest Diagnostics Recent Development

11.4 C₂N Diagnostics

11.4.1 C₂N Diagnostics Company Details

11.4.2 C₂N Diagnostics Business Overview

11.4.3 C₂N Diagnostics Alzheimer's Disease Diagnosis Introduction

11.4.4 C₂N Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.4.5 C₂N Diagnostics Recent Development

11.5 Fujirebio

11.5.1 Fujirebio Company Details

11.5.2 Fujirebio Business Overview

11.5.3 Fujirebio Alzheimer's Disease Diagnosis Introduction

11.5.4 Fujirebio Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.5.5 Fujirebio Recent Development

11.6 Diadem

11.6.1 Diadem Company Details

11.6.2 Diadem Business Overview

11.6.3 Diadem Alzheimer's Disease Diagnosis Introduction

11.6.4 Diadem Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.6.5 Diadem Recent Development

11.7 Labcorp

11.7.1 Labcorp Company Details

11.7.2 Labcorp Business Overview

11.7.3 Labcorp Alzheimer's Disease Diagnosis Introduction

11.7.4 Labcorp Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.7.5 Labcorp Recent Development

11.8 Neurocode

11.8.1 Neurocode Company Details

11.8.2 Neurocode Business Overview

11.8.3 Neurocode Alzheimer's Disease Diagnosis Introduction

11.8.4 Neurocode Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.8.5 Neurocode Recent Development

11.9 Cognitact

11.9.1 Cognitact Company Details

11.9.2 Cognitact Business Overview

11.9.3 Cognitact Alzheimer's Disease Diagnosis Introduction

11.9.4 Cognitact Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.9.5 Cognitact Recent Development

11.10 EUROIMMUN Medical Diagnostics

11.10.1 EUROIMMUN Medical Diagnostics Company Details

11.10.2 EUROIMMUN Medical Diagnostics Business Overview

11.10.3 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Introduction

11.10.4 EUROIMMUN Medical Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.10.5 EUROIMMUN Medical Diagnostics Recent Development

11.11 Vazyme International

11.11.1 Vazyme International Company Details

11.11.2 Vazyme International Business Overview

11.11.3 Vazyme International Alzheimer's Disease Diagnosis Introduction

11.11.4 Vazyme International Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.11.5 Vazyme International Recent Development

11.12 KingMed Diagnostics

11.12.1 KingMed Diagnostics Company Details

11.12.2 KingMed Diagnostics Business Overview

11.12.3 KingMed Diagnostics Alzheimer's Disease Diagnosis Introduction

11.12.4 KingMed Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.12.5 KingMed Diagnostics Recent Development

11.13 Hoyotek

11.13.1 Hoyotek Company Details

11.13.2 Hoyotek Business Overview

11.13.3 Hoyotek Alzheimer's Disease Diagnosis Introduction

11.13.4 Hoyotek Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.13.5 Hoyotek Recent Development

11.14 Carrier Biomed

11.14.1 Carrier Biomed Company Details

11.14.2 Carrier Biomed Business Overview

11.14.3 Carrier Biomed Alzheimer's Disease Diagnosis Introduction

11.14.4 Carrier Biomed Revenue in Alzheimer's Disease Diagnosis Business (2021–2026)

11.14.5 Carrier Biomed Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Quanterix

Quest Diagnostics

C₂N Diagnostics

Fujirebio

DIADEM

LabCorp

Neurocode

Cognitact

Vazyme International

Kingmed Diagnostics

Hoyotek

EUROIMMUN Medical Diagnostics

Carrier Biomed

List of Tables

Table 1. Global Alzheimer's Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Neuroimaging Examination

Table 3. Key Players of Cerebrospinal Fluid Examination

Table 4. Key Players of Peripheral Blood Antibody Examination

Table 5. Key Players of Others

Table 6. Global Alzheimer's Disease Diagnosis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Alzheimer's Disease Diagnosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Alzheimer's Disease Diagnosis Market Size by Region (US$ Million), 2021–2026

Table 9. Global Alzheimer's Disease Diagnosis Market Share by Region (2021–2026)

Table 10. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Alzheimer's Disease Diagnosis Market Share by Region (2027–2032)

Table 12. Alzheimer's Disease Diagnosis Market Trends

Table 13. Alzheimer's Disease Diagnosis Market Drivers

Table 14. Alzheimer's Disease Diagnosis Market Challenges

Table 15. Alzheimer's Disease Diagnosis Market Restraints

Table 16. Global Alzheimer's Disease Diagnosis Revenue by Players (US$ Million), 2021–2026

Table 17. Global Alzheimer's Disease Diagnosis Market Share by Players (2021–2026)

Table 18. Global Top Alzheimer's Disease Diagnosis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Alzheimer's Disease Diagnosis Revenue, 2025

Table 19. Ranking of Global Top Alzheimer's Disease Diagnosis Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnosis Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Alzheimer's Disease Diagnosis, Headquarters and Area Served

Table 22. Global Key Players of Alzheimer's Disease Diagnosis, Products and Applications

Table 23. Global Key Players of Alzheimer's Disease Diagnosis, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Alzheimer's Disease Diagnosis Market Size by Type (US$ Million), 2021–2026

Table 26. Global Alzheimer's Disease Diagnosis Revenue Market Share by Type (2021–2026)

Table 27. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Alzheimer's Disease Diagnosis Revenue Market Share by Type (2027–2032)

Table 29. Global Alzheimer's Disease Diagnosis Market Size by Application (US$ Million), 2021–2026

Table 30. Global Alzheimer's Disease Diagnosis Revenue Market Share by Application (2021–2026)

Table 31. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Alzheimer's Disease Diagnosis Revenue Market Share by Application (2027–2032)

Table 33. North America Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Alzheimer's Disease Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 35. North America Alzheimer's Disease Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Alzheimer's Disease Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Alzheimer's Disease Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Alzheimer's Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Alzheimer's Disease Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Alzheimer's Disease Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Alzheimer's Disease Diagnosis Product

Table 51. Roche Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 52. Roche Recent Development

Table 53. Quanterix Company Details

Table 54. Quanterix Business Overview

Table 55. Quanterix Alzheimer's Disease Diagnosis Product

Table 56. Quanterix Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 57. Quanterix Recent Development

Table 58. Quest Diagnostics Company Details

Table 59. Quest Diagnostics Business Overview

Table 60. Quest Diagnostics Alzheimer's Disease Diagnosis Product

Table 61. Quest Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 62. Quest Diagnostics Recent Development

Table 63. C₂N Diagnostics Company Details

Table 64. C₂N Diagnostics Business Overview

Table 65. C₂N Diagnostics Alzheimer's Disease Diagnosis Product

Table 66. C₂N Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 67. C₂N Diagnostics Recent Development

Table 68. Fujirebio Company Details

Table 69. Fujirebio Business Overview

Table 70. Fujirebio Alzheimer's Disease Diagnosis Product

Table 71. Fujirebio Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 72. Fujirebio Recent Development

Table 73. Diadem Company Details

Table 74. Diadem Business Overview

Table 75. Diadem Alzheimer's Disease Diagnosis Product

Table 76. Diadem Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 77. Diadem Recent Development

Table 78. Labcorp Company Details

Table 79. Labcorp Business Overview

Table 80. Labcorp Alzheimer's Disease Diagnosis Product

Table 81. Labcorp Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 82. Labcorp Recent Development

Table 83. Neurocode Company Details

Table 84. Neurocode Business Overview

Table 85. Neurocode Alzheimer's Disease Diagnosis Product

Table 86. Neurocode Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 87. Neurocode Recent Development

Table 88. Cognitact Company Details

Table 89. Cognitact Business Overview

Table 90. Cognitact Alzheimer's Disease Diagnosis Product

Table 91. Cognitact Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 92. Cognitact Recent Development

Table 93. EUROIMMUN Medical Diagnostics Company Details

Table 94. EUROIMMUN Medical Diagnostics Business Overview

Table 95. EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Product

Table 96. EUROIMMUN Medical Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 97. EUROIMMUN Medical Diagnostics Recent Development

Table 98. Vazyme International Company Details

Table 99. Vazyme International Business Overview

Table 100. Vazyme International Alzheimer's Disease Diagnosis Product

Table 101. Vazyme International Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 102. Vazyme International Recent Development

Table 103. KingMed Diagnostics Company Details

Table 104. KingMed Diagnostics Business Overview

Table 105. KingMed Diagnostics Alzheimer's Disease Diagnosis Product

Table 106. KingMed Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 107. KingMed Diagnostics Recent Development

Table 108. Hoyotek Company Details

Table 109. Hoyotek Business Overview

Table 110. Hoyotek Alzheimer's Disease Diagnosis Product

Table 111. Hoyotek Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 112. Hoyotek Recent Development

Table 113. Carrier Biomed Company Details

Table 114. Carrier Biomed Business Overview

Table 115. Carrier Biomed Alzheimer's Disease Diagnosis Product

Table 116. Carrier Biomed Revenue in Alzheimer's Disease Diagnosis Business (US$ Million), 2021–2026

Table 117. Carrier Biomed Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Alzheimer's Disease Diagnosis Picture

Figure 2. Global Alzheimer's Disease Diagnosis Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Alzheimer's Disease Diagnosis Market Share by Type: 2025 vs 2032

Figure 4. Neuroimaging Examination Features

Figure 5. Cerebrospinal Fluid Examination Features

Figure 6. Peripheral Blood Antibody Examination Features

Figure 7. Others Features

Figure 8. Global Alzheimer's Disease Diagnosis Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Alzheimer's Disease Diagnosis Market Share by Application: 2025 vs 2032

Figure 10. Clinical Diagnosis Case Studies

Figure 11. Research Case Studies

Figure 12. Alzheimer's Disease Diagnosis Report Years Considered

Figure 13. Global Alzheimer's Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Alzheimer's Disease Diagnosis Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Alzheimer's Disease Diagnosis Market Share by Region: 2025 vs 2032

Figure 16. Global Alzheimer's Disease Diagnosis Market Share by Players in 2025

Figure 17. Global Alzheimer's Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnosis Revenue in 2025

Figure 19. North America Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Alzheimer's Disease Diagnosis Market Share by Country (2021–2032)

Figure 21. United States Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Alzheimer's Disease Diagnosis Market Share by Country (2021–2032)

Figure 25. Germany Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Alzheimer's Disease Diagnosis Market Share by Region (2021–2032)

Figure 33. China Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Alzheimer's Disease Diagnosis Market Share by Country (2021–2032)

Figure 41. Mexico Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Alzheimer's Disease Diagnosis Market Share by Country (2021–2032)

Figure 45. Israel Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Alzheimer's Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Roche Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 49. Quanterix Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 50. Quest Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 51. C₂N Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 52. Fujirebio Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 53. Diadem Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 54. Labcorp Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 55. Neurocode Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 56. Cognitact Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 57. EUROIMMUN Medical Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 58. Vazyme International Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 59. KingMed Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 60. Hoyotek Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 61. Carrier Biomed Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Blood based Detection Kit for Early Diagnosis of Alzheimer s Disease Market Research Report 2024

Global Alzheimer s Disease Blood Test Kit Market Research Report 2024

Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Blood Tests for Alzheimer s Diagnosis Market Research Report 2024

Global Alzheimer s Disease Blood Diagnostic Market Research Report 2024

Global Alzheimer s Blood Tests Market Research Report 2024

Global Dementia Diagnosis Solutions Market Research Report 2024

Global Alzheimer s Disease Biomarker Market Research Report 2024

Alzheimer Disease Genetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alzheimer s Disease Treatments Market Research Report 2024

Global Neurology Diagnostics Devices Market Research Report 2025

Alzheimer Disease DNA Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alzheimer s Disease AD Blood based Detection Kits Market Research Report 2024

Global Alzheimer s Disease Drug Market Insights Forecast to 2030

Global Animal Health Diagnosis Market Insights Forecast to 2030

Global Alzheimer Treatment Drug Market Research Report 2025

Global Neurological Biomarkers for Alzheimer s and Parkinson s Diseases Market Research Report 2025

Global Neurodiagnostic Devices Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions